| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Joanna Wardlaw | Q25272201 |
| P2093 | author name string | Michael J Thrippleton | |
| Maria Del C Valdés Hernández | |||
| Anna K Heye | |||
| Ross D Culling | |||
| P2860 | cites work | Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions | Q57041402 |
| Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI | Q58297047 | ||
| Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot | Q60584978 | ||
| Automatic determination of arterial input function for dynamic contrast enhanced MRI in tumor assessment | Q62488321 | ||
| Simplified, noninvasive PET measurement of blood-brain barrier permeability | Q70337223 | ||
| Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers | Q70685636 | ||
| Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors | Q74130951 | ||
| Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes | Q80794685 | ||
| Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI | Q80990297 | ||
| Population-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosis | Q24632212 | ||
| Development, maintenance and disruption of the blood-brain barrier | Q26829668 | ||
| Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications | Q27013660 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions | Q30502812 | ||
| Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation | Q30575110 | ||
| Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis | Q30582849 | ||
| Classic models for dynamic contrast-enhanced MRI. | Q30626277 | ||
| Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications. | Q30653828 | ||
| Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. | Q51120063 | ||
| Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. | Q51436493 | ||
| Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. | Q51625325 | ||
| Tumour enhancing fraction (EnF) in glioma: relationship to tumour grade. | Q53370137 | ||
| Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade. | Q55461634 | ||
| Comparative study of methods for determining vascular permeability and blood volume in human gliomas. | Q55471802 | ||
| Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. | Q55475521 | ||
| Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening | Q30813589 | ||
| Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. | Q31032542 | ||
| In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging | Q31142710 | ||
| Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography | Q31150386 | ||
| Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measured by dynamic MRI. | Q33179626 | ||
| Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model | Q33215918 | ||
| Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots | Q33466585 | ||
| Spatiotemporal correlations between blood-brain barrier permeability and apparent diffusion coefficient in a rat model of ischemic stroke | Q33492311 | ||
| Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma | Q33525581 | ||
| An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab | Q33568752 | ||
| Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: Rat cerebral glioma blood volume determination | Q33646272 | ||
| Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. | Q33744660 | ||
| The MRI-measured arterial input function resulting from a bolus injection of Gd-DTPA in a rat model of stroke slightly underestimates that of Gd-[14C]DTPA and marginally overestimates the blood-to-brain influx rate constant determined by Patlak plot | Q33890243 | ||
| Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences | Q33951156 | ||
| Pilot study on evaluation of any correlation between MR perfusion (Ktrans) and diffusion (apparent diffusion coefficient) parameters in brain tumors at 3 Tesla | Q34139839 | ||
| Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients | Q34727128 | ||
| Arterial input function in perfusion MRI: a comprehensive review | Q35003516 | ||
| DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model | Q35018356 | ||
| Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging | Q35470433 | ||
| Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. | Q35600833 | ||
| Model selection for DCE-T1 studies in glioblastoma | Q35798764 | ||
| Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model. | Q35925126 | ||
| Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas | Q36103551 | ||
| In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis | Q36453130 | ||
| The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment | Q36457747 | ||
| Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters | Q36602748 | ||
| Blood-brain barrier permeability abnormalities in vascular cognitive impairment | Q36644309 | ||
| Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors | Q36731879 | ||
| Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique | Q36784358 | ||
| Magnetic resonance imaging profile of blood-brain barrier injury in patients with acute intracerebral hemorrhage | Q36974297 | ||
| Quantitative measurement of blood-brain barrier permeability in human using dynamic contrast-enhanced MRI with fast T1 mapping | Q37108898 | ||
| Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction. | Q37235548 | ||
| Dynamic contrast enhanced MRI parameters and tumor cellularity in a rat model of cerebral glioma at 7 T. | Q37407972 | ||
| Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI | Q37414011 | ||
| Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability | Q37968863 | ||
| Neurological diseases in relation to the blood-brain barrier | Q37976564 | ||
| Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies | Q37983692 | ||
| Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. | Q38007857 | ||
| Overview and introduction: the blood-brain barrier in health and disease | Q38058369 | ||
| Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities | Q39729727 | ||
| Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade | Q41736519 | ||
| Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. | Q42629066 | ||
| Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population | Q42917550 | ||
| Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging | Q43405668 | ||
| Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. | Q43611164 | ||
| Post-ischemic blood-brain barrier leakage in rats: one-week follow-up by MRI. | Q46007232 | ||
| A new denoising method for dynamic contrast-enhanced MRI. | Q46041075 | ||
| On the scope and interpretation of the Tofts models for DCE-MRI. | Q46265644 | ||
| Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls | Q46305128 | ||
| An improved coverage and spatial resolution--using dual injection dynamic contrast-enhanced (ICE-DICE) MRI: a novel dynamic contrast-enhanced technique for cerebral tumors | Q47389075 | ||
| Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). | Q48142886 | ||
| MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model | Q48150297 | ||
| Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation. | Q48289741 | ||
| Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy. | Q48311455 | ||
| Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results | Q48327067 | ||
| Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms. | Q48417894 | ||
| Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhanced T(1)-weighted MRI at 3 tesla. | Q48450292 | ||
| Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. | Q48475147 | ||
| Pharmacokinetic modeling of Gd-DTPA extravasation in brain tumors. | Q48479389 | ||
| Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan? | Q48479931 | ||
| Recombinant tissue plasminogen activator increases blood-brain barrier disruption in acute ischemic stroke: an MR imaging permeability study. | Q48492153 | ||
| Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging. | Q48598553 | ||
| Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. | Q48611106 | ||
| Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. | Q48637034 | ||
| Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study. | Q48702160 | ||
| Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. | Q48717284 | ||
| Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. | Q48734816 | ||
| Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. | Q48750738 | ||
| Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma. | Q48758052 | ||
| A useful tool for the initial assessment of blood-brain barrier permeability after traumatic brain injury in rabbits: dynamic contrast-enhanced magnetic resonance imaging. | Q48766934 | ||
| Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. | Q48797418 | ||
| Dual dynamic contrast-enhanced MR imaging. | Q48807790 | ||
| Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. | Q48884217 | ||
| Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP-9) expression in brain tuberculomas. | Q48934093 | ||
| Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. | Q49045389 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | nervous system | Q9404 |
| magnetic resonance imaging | Q161238 | ||
| blood–brain barrier | Q221694 | ||
| systematic review | Q1504425 | ||
| circulatory system | Q11068 | ||
| P304 | page(s) | 262-274 | |
| P577 | publication date | 2014-09-10 | |
| P1433 | published in | NeuroImage: Clinical | Q22907265 |
| P1476 | title | Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review | |
| P478 | volume | 6 |
| Q64117189 | Alterations in Blood-Brain Barrier Permeability in Patients with Systemic Lupus Erythematosus |
| Q36231584 | Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model |
| Q38962380 | An adaptive model for rapid and direct estimation of extravascular extracellular space in dynamic contrast enhanced MRI studies. |
| Q40109121 | Application of Texture Analysis to Study Small Vessel Disease and Blood-Brain Barrier Integrity |
| Q49204998 | Application of a Simplified Method for Estimating Perfusion Derived from Diffusion-Weighted MR Imaging in Glioma Grading. |
| Q30990964 | Assessing Treatment Response Through Generalized Pharmacokinetic Modeling of DCE-MRI Data |
| Q47860539 | Assessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI. |
| Q51058288 | Assessment of active and inactive sacroiliitis in patients with ankylosing spondylitis using quantitative dynamic contrast-enhanced MRI. |
| Q48226842 | Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI. |
| Q48263259 | BOLD neurovascular coupling does not change significantly with normal aging |
| Q58696185 | Bayesian modeling of Dynamic Contrast Enhanced MRI data in cerebral glioma patients improves the diagnostic quality of hemodynamic parameter maps |
| Q53513684 | Blood-Brain Barrier Disruption and Perivascular Beta-Amyloid Accumulation in the Brain of Aged Rats with Spontaneous Hypertension: Evaluation with Dynamic Contrast-Enhanced Magnetic Resonance Imaging. |
| Q46644811 | Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. |
| Q30873200 | Blood-brain barrier imaging in human neuropathologies |
| Q39002038 | Blood-brain barrier permeability of normal-appearing white matter in patients with vestibular schwannoma: A new hybrid approach for analysis of T1 -W DCE-MRI. |
| Q48334832 | Blood-brain barrier: an impediment to neuropharmaceuticals |
| Q30363574 | Brain Vascular Imaging Techniques |
| Q36822034 | CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors |
| Q48826615 | CT Permeability Imaging Predicts Clinical Outcomes in Acute Ischemic Stroke Patients Treated with Intra-arterial Thrombolytic Therapy. |
| Q38879090 | Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease |
| Q100737114 | Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis |
| Q60916453 | Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI |
| Q30252533 | Critical role of matrix metallopeptidase 9 in postoperative cognitive dysfunction and age-dependent cognitive decline |
| Q61453310 | Current progress in searching for clinically useful biomarkers of blood-brain barrier damage following cerebral ischemia |
| Q38764240 | DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique |
| Q39005549 | Diffusion-compensated tofts model suggests contrast leakage through aneurysm wall |
| Q39177357 | Direct estimation of tracer-kinetic parameter maps from highly undersampled brain dynamic contrast enhanced MRI. |
| Q35649716 | Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? |
| Q41000474 | Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function |
| Q59792916 | Dynamic contrast-enhanced magnetic resonance imaging may act as a biomarker for vascular damage in normal appearing brain tissue after radiotherapy in patients with glioblastoma |
| Q48317096 | Early Blood Brain Barrier Changes in Acute Ischemic Stroke: A Sequential MRI Study |
| Q88622891 | Fast magnetic resonance fingerprinting for dynamic contrast-enhanced studies in mice |
| Q28600963 | High-resolution whole-brain DCE-MRI using constrained reconstruction: Prospective clinical evaluation in brain tumor patients |
| Q47683192 | Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden |
| Q60044237 | Hyperpolarized [1-13C] pyruvate MR spectroscopy detect altered glycolysis in the brain of a cognitively impaired mouse model fed high-fat diet |
| Q88576622 | Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI |
| Q90666922 | Impact of (k,t) sampling on DCE MRI tracer kinetic parameter estimation in digital reference objects |
| Q54940444 | Impaired Cerebral Perfusion in Multiple Sclerosis: Relevance of Endothelial Factors. |
| Q38902139 | In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats. |
| Q31059488 | In Vivo Imaging of Human Neuroinflammation |
| Q48095085 | Intact blood-brain barrier during spontaneous attacks of migraine without aura: a 3T DCE-MRI study. |
| Q31051207 | Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease |
| Q58779843 | Intravoxel incoherent motion MRI in neurological and cerebrovascular diseases |
| Q46028234 | Joint arterial input function and tracer kinetic parameter estimation from undersampled dynamic contrast-enhanced MRI using a model consistency constraint. |
| Q39312420 | MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives. |
| Q30977551 | MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T. |
| Q90296231 | MRI measurement of blood-brain barrier leakage: minding the gaps |
| Q47650466 | MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies |
| Q26771930 | MRI/MRS in neuroinflammation: methodology and applications |
| Q31136759 | Magnetic resonance imaging of blood-brain barrier permeability in ischemic stroke using diffusion-weighted arterial spin labeling in rats |
| Q57181658 | Magnetic targeting of paclitaxel-loaded poly(lactic--glycolic acid)-based nanoparticles for the treatment of glioblastoma |
| Q90611564 | Mapping water exchange across the blood-brain barrier using 3D diffusion-prepared arterial spin labeled perfusion MRI |
| Q51744032 | Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time. |
| Q38997187 | Medical Imaging Informatics |
| Q35768413 | Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes |
| Q97418952 | Neuronal regulation of the blood-brain barrier and neurovascular coupling |
| Q42516186 | Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol. |
| Q43227382 | Novel cytogenic and neurovascular niches due to blood-brain barrier compromise in the chronic pain brain |
| Q36501363 | Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI |
| Q48674737 | Parameter estimation using weighted total least squares in the two-compartment exchange model. |
| Q39432877 | Psychosis: an autoimmune disease? |
| Q64915168 | Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations. |
| Q48105538 | Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood-Brain Barrier in Glioblastoma Patients Using an IVIVE-PBPK Modeling Approach |
| Q90403977 | R2* Relaxation Affects Pharmacokinetic Analysis of Dynamic Contrast-Enhanced MRI in Cancer and Underestimates Treatment Response at 7 T |
| Q48510098 | Radiation injury versus malignancy after stereotactic radiosurgery for brain metastases: impact of time-dependent changes in lesion morphology on MRI. |
| Q92489166 | Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models |
| Q31153877 | Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software |
| Q97538175 | Sera of elderly obstructive sleep apnea patients alter blood-brain barrier integrity in vitro: a pilot study |
| Q27322384 | Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug |
| Q38685168 | Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI. |
| Q31132207 | T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition? |
| Q50615683 | T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients. |
| Q38606106 | Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading |
| Q48813866 | The Role of Dynamic Contrast-Enhanced MR in Evaluating Level III Collateral Circulation in a Rat Model of Acute Ischemic Stroke. |
| Q30239749 | The blood brain barrier in Alzheimer's disease. |
| Q90641415 | The blood-brain barrier and blood-tumour barrier in brain tumours and metastases |
| Q90107233 | Therapeutic Potentials of Localized Blood-Brain Barrier Disruption by Noninvasive Transcranial Focused Ultrasound: A Technical Review |
| Q36408061 | Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability |
| Q38955071 | Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard |
| Q59356932 | Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease |
| Q30976213 | What are white matter hyperintensities made of? Relevance to vascular cognitive impairment |
Search more.